The study findings indicate that C-peptide concentration lacks strong predictive value for determining future insulin therapy ...

Elevated C-reactive protein (CRP) levels have previously been described before the onset of type 2 diabetes and gestational diabetes. We hypothesized that inflammation, as reflected by elevated ...

Vertex Pharmaceuticals has discontinued the development of VX-264, a type 1 diabetes (T1D ... failed to generate high enough levels of C-peptide, a biomarker of insulin production.

Ma et al. report the results of a long-term survival study that assessed the role of prediagnostic BMI and plasma C-peptide concentration in prostate-cancer-related mortality. These results show ...

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or ...

High LDL levels put you at ... inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists as part of a regular treatment regimen. If you’re living with diabetes, you can greatly reduce ...

As discussed above, the proof-of-principle studies using both anti-CD3 antibodies (teplizumab and otelixizumab) showed effects on surrogate markers (C-peptide preservation) in newly diagnosed Type ...

Learn how the complex signaling features of these receptors are illuminating diabetes research. Diabetes results from elevated blood glucose levels that ... as glucagon-like peptide-1, free ...

Preclinical data from an animal study of GPX-002 in T1D showed statistically significant decreases in insulin requirements, increases in c-peptide levels ... therapy work in diabetes through ...